Source: Annual Congress 2010 - The lung in haematological disorders



Rating:

Share or cite this content

Citations should be made in the following way:
J. Sierra (Barcelona, Spain). Understanding host defense impairment in haematological malignancies. Annual Congress 2010 - The lung in haematological disorders

Member's Comments

No comment yet.

Related content which might interest you: Differential diagnosis of drug-induced toxicity and infectious disorder in haematological malignancies Source: Annual Congress 2009 - PG7 Drug-induced pulmonary toxicity Year: 2009 Dysregulation of host defence peptides by environmental challenge: Can we mitigate the pathophysiology? Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Immunology and defence mechanism of the developing lung Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=60 Year: 2006 Differentiating between virus-driven host immune responses and host defence immune responses Source: International Congress 2015 – Mechanisms of virus-driven and host-defence immune responses in acute virus-induced asthma Year: 2015 Innate and adaptive immune response in lung diseases Source: International Congress 2019 – PG6 Immunodeficiencies in lung diseases Year: 2019 The lung in humoral immune deficiency: variety of manifestations Source: Annual Congress 2013 –Ceremony for ERS Award for Rare Pulmonary Disease (financially supported by GlaxoSmithKline) followed by Symposium: Autoimmunity and lung diseases in humans Year: 2013 Risk factors for impaired pulmonary function in adult survivors of childhood hematological and non-hematological malignancies Source: Virtual Congress 2020 – Management of chronic lung conditions Year: 2020 Determinants of lung cancer evolution: immune escape and inflammation Source: International Congress 2018 – Scientific Year in Review Year: 2018 Improving the innate immune response in respiratory infections: the use of repurposed drugs Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma Year: 2019 Relevance of innate immune responses to chronic airway diseases Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences Year: 2008 Changes parameters of non-specific immune defence during COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 511s Year: 2004 How infections can modify lung immunity Source: Guideline 2001 Year: 2001 How infections can modify lung immunity Source: Eur Respir J 2001; 18: 442-443 Year: 2001